| Journal Article |
File Downloads |
Abstract Views |
| Last month |
3 months |
12 months |
Total |
Last month |
3 months |
12 months |
Total |
| 12 Lessons learned from the management of the coronavirus pandemic |
0 |
0 |
0 |
3 |
0 |
0 |
1 |
29 |
| A Conceptual Framework for Community-Based Health Insurance in Low-Income Countries: Social Capital and Economic Development |
0 |
2 |
10 |
231 |
1 |
8 |
38 |
912 |
| A comparative study of drug listing recommendations and the decision-making process in Australia, the Netherlands, Sweden, and the UK |
0 |
0 |
0 |
2 |
1 |
1 |
3 |
30 |
| A pricing policy towards the sourcing of cheaper drugs in Cyprus |
0 |
0 |
0 |
7 |
0 |
0 |
0 |
58 |
| Accelerating integration of social needs into mainstream healthcare to achieve health equity in the COVID-19 era |
0 |
0 |
0 |
0 |
1 |
2 |
4 |
4 |
| An ethical appraisal of living-anonymous kidney donation using Adam Smith’s Theory of Moral Sentiments |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
14 |
| Analysing the Greek health system: a tale of fragmentation and inertia |
0 |
0 |
4 |
314 |
0 |
0 |
5 |
781 |
| Assessment of Devices, Diagnostics and Digital Technologies: A Review of NICE Medical Technologies Guidance |
0 |
1 |
1 |
6 |
0 |
1 |
3 |
40 |
| Association between provincial income levels and drug prices in China over the period 2010–2017 |
0 |
0 |
0 |
2 |
0 |
0 |
2 |
7 |
| Attitudes as an Expression of Knowledge and “Political Anchoring”: The Case of Nuclear Power in the United Kingdom |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
7 |
| Balancing economic freedom against social policy principles: EC competition law and national health systems |
0 |
0 |
0 |
8 |
0 |
0 |
3 |
40 |
| Behavioral adjustment to avian flu in Europe during spring 2006: The roles of knowledge and proximity to risk |
0 |
0 |
0 |
4 |
1 |
1 |
2 |
34 |
| Bioethical Implications of Globalization: An International Consortium Project of the European Commission |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
4 |
| COVID-19 anti-contagion policies and economic support measures in the USA |
0 |
0 |
0 |
4 |
0 |
0 |
9 |
28 |
| COVID-19 vaccine challenges: What have we learned so far and what remains to be done? |
0 |
0 |
0 |
4 |
0 |
0 |
2 |
17 |
| Citizens and rationing: analysis of a European survey |
0 |
0 |
0 |
10 |
0 |
0 |
2 |
46 |
| Citizens' Views on Health Care Systems in the 15 Member States of The European Union |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
175 |
| Clinical negligence cases in the English NHS: uncertainty in evidence as a driver of settlement costs and societal outcomes |
0 |
0 |
0 |
1 |
1 |
2 |
3 |
7 |
| Cost containment and health care reform: a study of the European Union |
0 |
1 |
2 |
335 |
1 |
2 |
5 |
750 |
| Crowdfunding our health: Economic risks and benefits |
0 |
0 |
0 |
15 |
0 |
2 |
3 |
73 |
| Does economic recession impact newborn health? Evidence from Greece |
0 |
0 |
1 |
4 |
0 |
0 |
2 |
86 |
| Does health insurance reduce out-of-pocket expenditure? Heterogeneity among China's middle-aged and elderly |
0 |
0 |
0 |
17 |
1 |
1 |
4 |
78 |
| Drawing light from the pandemic: Rethinking strategies for health policy and beyond |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
6 |
| Effectiveness of government policies in response to the first COVID-19 outbreak |
0 |
0 |
0 |
2 |
0 |
0 |
0 |
23 |
| Equity in health care use among older people in the UK: an analysis of panel data |
0 |
0 |
0 |
6 |
0 |
2 |
4 |
50 |
| Erratum to Will Managed Care Work in Europe? |
0 |
0 |
0 |
0 |
1 |
2 |
2 |
7 |
| Erring on the Side of Caution? The Heterogeneity of Public Perceptions of Biotechnology Applications in the European Union |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
6 |
| Evaluation of progress toward universal health coverage in Myanmar: A national and subnational analysis |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
5 |
| Expanding the role of community pharmacists: Policymaking in the absence of policy-relevant evidence? |
0 |
0 |
2 |
19 |
1 |
1 |
4 |
56 |
| Financial protection in health among the middle-aged and elderly: Evidence from the Greek economic recession |
0 |
0 |
1 |
1 |
1 |
1 |
4 |
7 |
| From “retailers” to health care providers: Transforming the role of community pharmacists in chronic disease management |
0 |
0 |
2 |
13 |
0 |
0 |
4 |
43 |
| Has the Portuguese NHS Achieved its Objectives of Equity and Efficiency? |
0 |
0 |
0 |
1 |
0 |
1 |
3 |
5 |
| Health policy in times of austerity—A conceptual framework for evaluating effects of policy on efficiency and equity illustrated with examples from Europe since 2008 |
0 |
0 |
0 |
7 |
1 |
1 |
1 |
23 |
| Is dread of Genetically Modified food associated with the consumers' demand for information? |
0 |
0 |
1 |
36 |
0 |
0 |
4 |
202 |
| Is there 'patient selection' in the demand for private maternity care in Greece? |
0 |
0 |
0 |
20 |
0 |
0 |
0 |
153 |
| Mapping support policies for informal carers across the European Union |
0 |
0 |
1 |
20 |
0 |
1 |
4 |
118 |
| Measuring socioeconomic differences in use of health care services by wealth versus by income |
0 |
0 |
1 |
1 |
0 |
0 |
2 |
13 |
| Optimism and the perceptions of new risks |
1 |
1 |
3 |
19 |
1 |
1 |
9 |
50 |
| Pharmaceutical Pricing in Europe: Weighing up the Options |
0 |
0 |
0 |
3 |
0 |
1 |
2 |
8 |
| Pharmaceutical pricing and reimbursement in China: When the whole is less than the sum of its parts |
0 |
0 |
2 |
31 |
0 |
0 |
4 |
97 |
| Promoting innovation while controlling cost: The UK's approach to health technology assessment |
0 |
0 |
0 |
2 |
0 |
0 |
0 |
7 |
| Relationship between costs and clinical benefits of new cancer medicines in Australia, France, the UK, and the US |
0 |
0 |
0 |
2 |
1 |
1 |
2 |
14 |
| Stimulating pharmaceutical research and development for neglected diseases |
0 |
0 |
0 |
12 |
0 |
0 |
1 |
49 |
| Systems, not pills: The options market for antibiotics seeks to rejuvenate the antibiotic pipeline |
0 |
0 |
0 |
2 |
0 |
0 |
0 |
12 |
| The EU Response to COVID‐19: From Reactive Policies to Strategic Decision‐Making |
0 |
0 |
0 |
3 |
0 |
1 |
4 |
11 |
| The European Court of Justice and the free movement of patients in the European Union |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
2 |
| The European Union and Health Policy, by Ed Randall. Palgrave, Hampshire and New York, 2001. No. of pages: xiii+278. ISBN 0‐333‐75426‐3.. The Implications of Recent Jurisprudence on the Co‐ordination of Health Care Protection Systems, by Willy Palm, Jason Nickless, Henri Lewalle and Alain Coheur. Association Internationale de la Mutualite, Brussess, 2000. No. of pages: 170. [http://europa.eu.int/comm/employment_social/soc‐prot/disable/report.pdf]. Health Care Without Frontiers? The Development of a European Market in Health Services by Lyndsay Mountford. Office of Health Econ‐omics, London, 2000. No. of pages: 83. ISBN 1‐899040‐71‐4 |
0 |
0 |
0 |
22 |
0 |
0 |
1 |
64 |
| The Impact of Alcohol Policies across Europe on Young Adults' Perceptions of Alcohol Risks |
0 |
0 |
0 |
7 |
1 |
1 |
3 |
46 |
| The Public as a Limit to Technology Transfer: The Influence of Knowledge and Beliefs in Attitudes towards Biotechnology in the UK |
0 |
0 |
0 |
40 |
0 |
0 |
0 |
196 |
| The contestable nature of health policy analysis |
0 |
0 |
0 |
46 |
0 |
0 |
0 |
143 |
| The impact of collaborative organisational models and general practice size on patient safety and quality of care in the English National Health Service: A systematic review |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
| The impact of primary health care and specialist physician supply on amenable mortality in Mexico (2000–2015): Panel data analysis using system-Generalized Method of Moments |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
6 |
| The impact of the Greek economic adjustment programme on household health expenditure |
0 |
0 |
0 |
3 |
0 |
0 |
1 |
41 |
| The launch of the EU Health Emergency Preparedness and Response Authority (HERA): Improving global pandemic preparedness? |
0 |
0 |
0 |
1 |
1 |
4 |
5 |
6 |
| The ‘Netflix plus model’: can subscription financing improve access to medicines in low- and middle-income countries? |
0 |
0 |
0 |
2 |
0 |
0 |
1 |
12 |
| When is the Internet a valued communication device for health information in Europe? |
0 |
0 |
0 |
19 |
1 |
1 |
1 |
133 |
| Which policies effectively enable smoking cessation? Evidence from the European Union |
0 |
0 |
1 |
1 |
1 |
2 |
4 |
4 |
| Total Journal Articles |
1 |
5 |
32 |
1,314 |
17 |
41 |
161 |
4,838 |
LogEc is hosted by the
Örebro University School of Business.